By positively transporting drugs across the plasma membrane, ABC transporters maintain a relatively low intracellular drug load, causing cancer cells to acquire a strong ability to counteract drug-induced toxicity (Kathawala et al., 2015; Robey et al., 2018). Here, ABCG2 is linked to cancer.